S1 Model.XLSX (1.07 MB)

Cost effectiveness model as described in the manuscript.

dataset

posted on 2016-04-21, 05:56 authored by Vincent T. Janmaat, Marco J. Bruno, Suzanne Polinder, Sylvie Lorenzen, Florian Lordick, Maikel P. Peppelenbosch, Manon C. W. Spaander

(XLSX)

History

Usage metrics

Keywords

cisplatin cetuximab cell carcinoma threshold cost effectiveness analysis model ratio cell carcinoma addition esophageal Monte Carlo analysis regimen Sensitivity analysis Advanced Esophageal Squamous Cell Carcinoma Background phase II trial data

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM